| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094716 1-Pyridin-4-yl-urea derivatives |
| 05/04/2006 | US20060094701 Respiratory system disorders; antiinflamamtory agents; side effect reduction; administering terbutaline |
| 05/04/2006 | CA2584413A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | CA2584318A1 Quinoline derivatives |
| 05/04/2006 | CA2581807A1 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 05/03/2006 | EP1652840A2 (-)-(S)-N-(.alpha.-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide |
| 05/03/2006 | EP1652839A2 Drug efflux pump inhibitor |
| 05/03/2006 | EP1651610A1 Quinoline derivates and their use in therapy |
| 05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1099692B1 N,n-substituted cyclic amine derivatives |
| 05/03/2006 | CN1768050A Benzopyran compounds useful for treating inflammatory conditions |
| 05/03/2006 | CN1768039A Process for producing quinoline compound |
| 05/03/2006 | CN1767823A Asthma and allergic inflammation modulators |
| 05/03/2006 | CN1765885A 2-methyl-3-hydroxy-6-isopropylquinoline-4-carboxyl acid preparation method |
| 05/02/2006 | US7038056 Method for preparing a 7-quinolinyl-3,5-dihydroxyhept-6-enoate |
| 05/02/2006 | US7038055 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies |
| 05/02/2006 | US7038052 Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline |
| 05/02/2006 | US7037941 Alpha-and Beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037913 Piperazinyl derivatives of naphthalenes, (iso)quinolines and naphthyridines; used particularly the treatment of HIV and AIDS. |
| 05/02/2006 | CA2250426C Amidinohydrazones as protease inhibitors |
| 04/27/2006 | WO2006043846A1 Salt of montelukast with tert.-butylamine |
| 04/27/2006 | WO2006028896A3 Chemical compounds |
| 04/27/2006 | WO2006008562A8 Process |
| 04/27/2006 | US20060089495 Heat shock protein 90 inhibitors |
| 04/27/2006 | US20060089381 Via liquid chromatography using packing material comprising carrier and polysaccharide, where part or all of hydrogen atoms of hydroxyl and amino groups of polysaccharide are substituted with substituents such as a carbamoyl group where one hydrogen is substituted with aromatic group with specific alkyl |
| 04/27/2006 | US20060089380 Treating nervous system disorders such as mild cognitive impairment, Alzheimer's disease or dementia associated with Down syndrome; e.g. use of 5,7-dichloro-8-hydroxy-2-(2-pyridyl)-quinoline (PBT 1052) |
| 04/27/2006 | US20060089348 neurokinin-2 and neurokinin-3 antagonists; schizophrenia, COPD, asthma, irritable bowel syndrome; N'-ethyl-3-methyloxy-N',2-diphenyl-4-quinolinecarbohydrazide |
| 04/27/2006 | DE10394213T5 Verfahren zur Synthses von Bis(4-substituierten Chinolyl)disulfiden A process for Synthses of bis (4-substituted-quinolyl) disulphides |
| 04/27/2006 | CA2584151A1 Method of treating human preeclampsia employing resibufagenin |
| 04/26/2006 | EP1650192A1 Quinolone derivative or salt thereof |
| 04/26/2006 | EP1650191A1 Therapeutic agent for chronic obstructive pulmonary disease and method of treatment for chronic obstructive pulmonary disease with the same |
| 04/26/2006 | EP1650190A1 3-aryl-3-methyl-quinoline-2,4-diones, preparation method thereof and pharmaceutical composition containing same |
| 04/26/2006 | EP1648870A2 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 04/26/2006 | EP1648858A1 Method for production of alpha, beta-unsaturated amide compounds |
| 04/26/2006 | CN1763013A 8-amidoquinaldine production method |
| 04/26/2006 | CN1253436C Large conjugated half cyanine dye, its synthesis and its sensitized nano-crystal semiconductor solar energy battery |
| 04/25/2006 | US7034182 Compounds to treat Alzheimer's disease |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034040 Fluorinated heterocyclic compounds and methods of synthesis |
| 04/25/2006 | CA2237313C Aromatic carboxylic acid esters, the production of same and use of same as medicaments |
| 04/20/2006 | WO2006041119A1 Hydrazide derivatives |
| 04/20/2006 | WO2006041056A1 Metal-containing coordination compound, coordination compound residue-containing polymer compound, organic electroluminescent material, white organic electroluminescent material, white light-emitting device, and light-emitting device |
| 04/20/2006 | WO2006040178A1 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006040004A1 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 04/20/2006 | WO2006013393A3 Quinoline derivatives as neurokinin receptor antagonists |
| 04/20/2006 | US20060084680 ((1S)-5-{2-[(3-methyl-7-propyl-1,2-benzisoxazol-6-yl)oxy]ethoxy}-2,3-dihydro-1H-inden-1-yl)acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic diseases; hyperglycemia, hyperinsulinemia, impaired glucose tolerance, dyslipidemia, hypertriglyceridemia, and insulin resistance |
| 04/20/2006 | US20060084679 Quinoline derivatives as H3R inverse agonists |
| 04/20/2006 | US20060084677 2-sulfo, sulfanyl, sulfinyl, sulfonyl, or sulfamyl-5-substituted-6-sulfonyl quinolines; sulfiding, oxidation, dehalogenation or aralkylation of the 6-sulfonylquinoline; selective cyclooxygenase-2 inhibitors, analgesics; side effect reduction |
| 04/20/2006 | US20060084676 selective serotonin receptor antagonists for treating central nervous system disorders; chemical synthesis |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
| 04/20/2006 | CA2583920A1 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 04/19/2006 | EP1647548A1 Dictionic bishydrazones, dyeingcompositions containig at least one of these compounds, process of their preparation and uses thereoff |
| 04/19/2006 | EP1646613A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 04/19/2006 | EP1646612A1 Processes for preparing montelukast sodium |
| 04/19/2006 | EP1253924B1 Nitrate salts of antimicrobial agents |
| 04/19/2006 | EP1239817B1 Use of methylchinolinium compounds for dyeing keratin containing fibers |
| 04/19/2006 | EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands |
| 04/19/2006 | CN1761644A Synthesis of 4-(amino)-2-butenoyl chlorides and their use in the preparation of 3-cyano quinolines |
| 04/19/2006 | CN1760183A New brand of Aripipazole, and preparation method |
| 04/19/2006 | CN1252054C Qinoline derivatives inhibiting effect of growth factors |
| 04/18/2006 | US7030246 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof |
| 04/18/2006 | US7030237 Continous separation of preferential compounds from sample; prepare liquid interphases, incubate with sample, recover compound |
| 04/18/2006 | US7030161 α-and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 04/18/2006 | US7030137 Substituted thiophenes with antibacterial activity |
| 04/18/2006 | US7030063 Cyclohexenonquinolinoyl-derivatives as herbicidal agents |
| 04/18/2006 | US7029765 Organic light emitting devices having reduced pixel shrinkage |
| 04/18/2006 | CA2414477C Lubricating compositions containing aromatized 1,2-dihydro-2,2,4-trimethylquinoline polymers |
| 04/18/2006 | CA2360943C N2-phenylamidine derivatives |
| 04/13/2006 | WO2006038594A1 N-type calcium channel inhibitor |
| 04/13/2006 | WO2006038587A1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery |
| 04/13/2006 | WO2006037996A1 Novel cyclic and acyclic propenones for treating cns disorders |
| 04/13/2006 | WO2006031556A3 Amidine substituted aryl aniline compounds |
| 04/13/2006 | WO2005007621A3 Ubiquitin ligase inhibitors |
| 04/13/2006 | US20060079690 Processes for preparing 7-hydroxy-3,4-dihydro-2(1H)-quinolinone and the use in aripiprazole preparation thereof |
| 04/13/2006 | US20060079553 Quinoline derivatives as glucokinase ligands |
| 04/13/2006 | US20060079551 Treatment of neurodegenerative diseases and cancer of the brain using histone deacetylase inhibitors |
| 04/13/2006 | US20060079528 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors |
| 04/13/2006 | US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/13/2006 | CA2582911A1 Chemokine-binding heterocyclic compound salts, and methods of use thereof |
| 04/13/2006 | CA2580221A1 Novel cyclic and acyclic propenones for treating cns disorders |
| 04/12/2006 | EP1645274A1 Process for making gatifloxacin form omega |
| 04/12/2006 | EP1644398A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 04/12/2006 | EP1644397A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 04/12/2006 | EP1644375A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/12/2006 | EP1644370A2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/12/2006 | EP1644335A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/12/2006 | EP1644330A2 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
| 04/12/2006 | EP1644323A2 Histone deacetylase inhibitors and methods of use thereof |
| 04/12/2006 | EP1644321A2 New benzamides as ppaty modulators |
| 04/12/2006 | EP1643960A2 Arylsulfonamide derivatives |
| 04/12/2006 | EP1355639B1 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 04/12/2006 | EP1311499B1 Bicyclic compounds as h3 receptor ligands |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP0903337B1 Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 04/12/2006 | CN1759101A Quinolinone / benzoxazinone derivatives and uses thereof |
| 04/12/2006 | CN1250540C Improved single-reactor synthesis of [2,8-di(trifluoromethyl)-4-quinolyl]-2-pyridyl methyl ketone and methylfluoro quine |